WallStSmart
FATE

Fate Therapeutics Inc

NASDAQ: FATE · HEALTHCARE · BIOTECHNOLOGY

$1.25
+0.81% today

Updated 2026-04-30

Market cap
$154.63M
P/E ratio
P/S ratio
23.27x
EPS (TTM)
$-1.15
Dividend yield
52W range
$1 – $2
Volume
1.4M

Fate Therapeutics Inc (FATE) Financial statements

SEC filings — annual and quarterly data.

Balance sheet — annual

Item20112012201320142015201620172018201920202021202220232024
Total assets$7.85M$11.08M$55.58M$51.20M$67.96M$95.05M$105.29M$213.03M$302.27M$622.46M$921.46M$705.56M$506.22M$440.69M
Cash & equivalents$6.39M$9.09M$54.04M$49.10M$64.81M$88.61M$88.95M$190.51M$99.81M$167.35M$133.58M$61.33M$41.87M$36.06M
Current assets$6.69M$9.79M$54.65M$49.87M$65.65M$93.32M$102.60M$205.20M$227.09M$494.32M$633.41M$502.07M$331.54M$291.91M
Total liabilities$58.53M$63.90M$4.74M$22.86M$29.92M$21.89M$28.10M$52.56M$57.52M$238.01M$242.62M$221.62M$137.80M$121.97M
Current liabilities$3.67M$4.85M$4.60M$4.58M$13.44M$15.19M$11.05M$27.26M$27.81M$85.56M$81.28M$114.05M$39.09M$38.52M
Long-term debt$3.59M$1.73M$0.00$18.08M$10.69M$2.50M$14.81M$12.45M
Shareholder equity$-50.68M$-52.83M$50.85M$28.34M$38.04M$73.15M$77.19M$160.47M$244.76M$384.44M$678.84M$483.94M$368.42M$318.73M
Retained earnings$-51.38M$-65.61M$-86.51M$-112.39M$-142.38M$-175.85M$-218.80M$-285.40M$-383.55M$-556.93M$-769.08M$-1.05B$-1.21B$-1.40B
Accounts receivable$500000.00$1.34M$5.51M$8.68M$38.48M$1.83M$3.54M
Inventory$0.00$0.00$0.00$0.00$0.00$1.00$1.00$1.00
Goodwill$0.00$0.00$0.00$0.00$0.00